Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

meeting   crawled time : 12:20    save search

YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting
Published: 2024-02-18 (Crawled : 12:20) - prnewswire.com
YS | $0.814 0.38% 0.38% 24K twitter stocktwits trandingview |
n/a
| Email alert Add to watchlist

biopharma meeting results
Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2023-11-04 (Crawled : 12:20) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist

gda-201 candidate natural cancer cell immunotherapy meeting therapy
ADVENT Study of the FARAPULSE™ Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints
Published: 2023-08-27 (Crawled : 12:20) - prnewswire.com
BSX | $72.91 5.68% -0.03% 15M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

system study
FSD Pharma Selected to Present its Phase 1 Data on Lucid-MS at MSMilan 2023 – 9th Joint ECTRIMS-ACTRIMS Meeting for October 11-13, 2023
Published: 2023-08-15 (Crawled : 12:20) - biospace.com/
HUGE | News | $0.4634 -5.24% -5.52% 280K twitter stocktwits trandingview |
Process Industries
| | O: -3.11% H: 9.29% C: 2.14%

pharma lucid-ms meeting
Evoke Pharma and EVERSANA Announce Abstract Acceptance at 2023 American Neurogastroenterology and Motility Society (ANMS) Meeting
Published: 2023-08-07 (Crawled : 12:20) - globenewswire.com
EVOK | $0.433 -2.37% -2.42% 9K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -7.84%

pharma eversana meeting
Precision BioSciences Provides Updates on Azer-Cel FDA Meeting, Potential Partnerships and Timing of In Vivo R&D Day
Published: 2023-07-27 (Crawled : 12:20) - precisionbiosciences.com
DTIL | $9.81 -4.11% -4.28% 34K twitter stocktwits trandingview |
Health Technology
| | O: 0.85% H: 3.31% C: -4.07%

day fda potential
Immix Biopharma Subsidiary Nexcella Announces NXC-201 Multiple Myeloma Clinical Data Abstract Accepted for Presentation at the 20th International Myeloma Society Annual Meeting
Published: 2023-07-25 (Crawled : 12:20) - globenewswire.com
IMMX | $2.15 -6.52% -6.98% 60K twitter stocktwits trandingview |
| | O: -1.45% H: 5.15% C: 0.49%

nxc-201 presentation international biopharma meeting
Moxian to Hold Annual Meeting of Shareholders on August 25, 2023
Published: 2023-07-18 (Crawled : 12:20) - globenewswire.com
MOXC | $1.01 0.99% 66K twitter stocktwits trandingview |
Technology Services
| | O: -0.32% H: 4.01% C: 4.01%

meeting
Adial Provides Business Update Following Favorable Comments from US and EU Regulatory Meetings
Published: 2023-07-11 (Crawled : 12:20) - globenewswire.com
ADIL | News | $1.72 1.18% 1.16% 140K twitter stocktwits trandingview |
Health Technology
| | O: 8.4% H: 155.36% C: 75.56%

business favorable update
Genesis Unicorn Capital Corp. Announces Filing and Mailing of Definitive Proxy Statement and Special Meeting Date for Proposed Business Combination with Environmental Solutions Group Holdings Limited
Published: 2023-07-07 (Crawled : 12:20) - globenewswire.com
GENQ | $10.47 23.06% 90K twitter stocktwits trandingview |
n/a
| | O: -0.37% H: 0.0% C: -0.09%

business group solutions meeting
Cellectar Biosciences Highlights Promising Interim Data from Its Ongoing Study of Iopofosine I 131 in Multiple Myeloma in an Oral Presentation at the SNMMI Annual Meeting
Published: 2023-06-28 (Crawled : 12:20) - globenewswire.com
CLRB | $3.045 -2.09% -2.13% 1M twitter stocktwits trandingview |
Health Technology
| | O: 3.67% H: 0.65% C: -3.02%

presentation ongoing meeting study
ReShape Lifesciences® Presents Data on its Proprietary Diabetes Bloc-Stim Neuromodulation™ Device at the ASMBS 2023 Annual Meeting
Published: 2023-06-28 (Crawled : 12:20) - globenewswire.com
RSLS | $0.1705 3.93% 120K twitter stocktwits trandingview |
Manufacturing
| | O: -1.32% H: 0.81% C: -5.37%

lifesciences device meeting diabetes
Panbela Announces Poster Presentation at the Endocrine Society Meeting: Polyamine Inhibition and β-Cell Preservation in Recent Onset Type 1 Diabetes
Published: 2023-06-26 (Crawled : 12:20) - globenewswire.com
PBLA | News | $0.42 -6.31% 64K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 0.89% H: 0.73% C: -9.29%

presentation endocrine diabetes
Quirk Auto Group selects BIO-key’s PortalGuard® Cloud Solution to Meet Updated GLBA Act Safeguards Rule Requirements to Protect Consumer Data
Published: 2023-06-20 (Crawled : 12:20) - globenewswire.com
BKYI | News | $1.64 -4.4% 14K twitter stocktwits trandingview |
Technology Services
| | O: -1.4% H: 6.37% C: 6.24%

portalguard solution group cloud
Voting Results from Constellium’s 2023 Annual General Meeting
Published: 2023-06-16 (Crawled : 12:20) - globenewswire.com
CSTM | $19.99 -6.28% 1.05% 2.5M twitter stocktwits trandingview |
Commercial Services
| | O: 0.89% H: 0.12% C: -1.59%

meeting results
Navitas to Present Next-Gen GaN & SiC Semiconductors at Taiwan Investor Meeting
Published: 2023-06-09 (Crawled : 12:20) - globenewswire.com
NVTS | $4.135 9.1% 8.34% 2.6M twitter stocktwits trandingview |
Manufacturing
| | O: 0.64% H: 0.91% C: -1.39%

meeting
Portage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of Advanced Melanoma and Metastatic Non-Small Cell Lung Cancer at the 2023 American Society for Clinical Oncology (ASCO) Annual Meeting
Published: 2023-06-05 (Crawled : 12:20) - globenewswire.com
PRTG | $0.265 9.23% 8.45% 180K twitter stocktwits trandingview |
Mining, Quarrying, and Oil and ...
| | O: 2.47% H: 17.65% C: 0.8%

lung melanoma biotech cancer cell treatment meeting trial
Panbela Announces Poster Presentation at Immunology of Diabetes Society Meeting: Evaluating the Potential of CPP-1X (Eflornithine) in Recent Onset Type 1 Diabetes
Published: 2023-06-01 (Crawled : 12:20) - globenewswire.com
PBLA | News | $0.42 -6.31% 64K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 2.03% H: 0.0% C: 0.0%

presentation immunology diabetes potential
DIRTT Announces Results of Annual and Special Meeting of Shareholders; Leadership Changes
Published: 2023-05-31 (Crawled : 12:20) - globenewswire.com
DRTT | News | $0.3343 -14.78% 260K twitter stocktwits trandingview |
Consumer Durables
| | O: -7.24% H: 8.09% C: 3.54%

meeting results
Moderna Announces Phase 2 Data on mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, to be Presented at the 2023 ASCO Annual Meeting
Published: 2023-05-30 (Crawled : 12:20) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 2.19% C: 1.91%

rna-4157 asco meeting
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.